is ozempic approved for prediabetes

No, Ozempic (semaglutide) is not currently approved by the FDA for the treatment of prediabetes. Ozempic is primarily approved for:

• Type 2 Diabetes Management: To improve blood sugar control in adults with type 2 diabetes.
• Cardiovascular Risk Reduction: To reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease.

However, some healthcare providers may prescribe Ozempic off-label for prediabetes or weight management, as it has shown benefits in improving insulin sensitivity and promoting weight loss. Always consult your healthcare provider for personalized advice.